N-Terminal PRO B-Type Natriuretic Peptide Levels in Neonates with Patent Ductus Arteriosus and Their Modulation by Treatment

Ali Elsayed Ahmed;

Abstract


A hemodynamically significant patent ductus arteriosus (sPDA) is a common and important cause of neonatal morbidity and mortality, which requires early therapy. Echocardiographic diagnosis requires expensive equipment and operator experience, which may no

Other data

Title N-Terminal PRO B-Type Natriuretic Peptide Levels in Neonates with Patent Ductus Arteriosus and Their Modulation by Treatment
Other Titles قياس مستويات البروببتيد نوع ب المدر للصوديوم ذو النهاية (ان) فى الأطفال حديثى الولادة ذو الوصلة الشريانية المفتوحة ومعدل تغير مستوياته بالعلاج
Authors Ali Elsayed Ahmed
Keywords N-Terminal PRO B-Type Natriuretic Peptide Levels in Neonates with Patent Ductus Arteriosus and Their Modulation by Treatment
Issue Date 2010
Description 
A hemodynamically significant patent ductus arteriosus (sPDA) is a common and important cause of neonatal morbidity and mortality, which requires early therapy. Echocardiographic diagnosis requires expensive equipment and operator experience, which may no

Attached Files

File SizeFormat
90748Thesis.pdf491.26 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 4 in Shams Scholar
downloads 2 in Shams Scholar
N-Terminal PRO B-Type Natriuretic Peptide Levels in Neonates with Patent Ductus Arteriosus and Their Modulation by Treatment


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.